We are very happy to attend the 3rd Next-Generation Conjugates Summit of Boston 2024, organized by Hanson Wade from 26th to 28th of February.
The focus of this Summit is on the driving Innovation in Novel Payload & Format Conjugate Design, Establishing Clinical Validation, & Streamlining CMC to Expand the Toolkit of Conjugate Drug Design & Development
Monumental successes from the ADC field are pushing drug developers to think outside the box with their drug design.
The 3rd Next-Generation Conjugates Summit returns as a hotbed of discussion of novel formats and payloads beyond traditional mAbs and cytotoxic payloads. In this edition will be showcasing advancements in antibody-oligonucleotide, fragment-drug conjugates, small molecule conjugates, targeted adiopharmaceuticals and more.
BSP's team looks forward to meeting You at our booth in the Exhibitor area
To request a meeting, please send an e-mail to Business.Development@Bsppharmaceuticals.com
Save the Date!!! Next Tuesday, 27th February 2024, our Giorgio Salciarini (Marketing & Business Development Manager), will presents to other guests its speech 'Our history to serve the Innovators: a step ahead against the Challenges of Bioconjugate' during the Conference Day1, from 09:30 AM.
